Literature DB >> 8405322

Seroprevalence to some TORCH agents in a Sicilian female population of fertile age.

F Condorelli1, G Scalia, A Stivala, M C Costanzo, A D Adragna, C Franceschino, M G Santagati, P M Furneri, A Marino, A Castro.   

Abstract

The seroprevalence to Toxoplasma gondii (41.1%), rubella virus (88.2%), cytomegalovirus (86.0%), and herpes simplex virus (80.0%) has been evaluated in fertile women living in Catania (Sicily). The population group studied was divided into four age groups to quantify the risk of primary infection in each age group.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8405322     DOI： 10.1007/bf00146274

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  8 in total

1.  Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987.

Authors:  M Forsgren; E Gille; I Ljungström; D J Nokes
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

2.  Incidence of congenital rubella syndrome in 19 regions of Europe in 1980-1986.

Authors:  I De la Mata; P De Wals; H Dolk; M F Lechat; R Beckers; I Borlee; F Lys; R Zori; J Goujard; C Stoll
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

Review 3.  Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections.

Authors:  S Stagno; R J Whitley
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

Review 4.  Infections with herpes simplex viruses (1).

Authors:  L Corey; P G Spear
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

5.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

6.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Policies for immunization against rubella in European countries.

Authors:  I De la Mata; P De Wals
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

Review 8.  Chronic congenital infections of man.

Authors:  C A Alford
Journal:  Yale J Biol Med       Date:  1982 May-Aug
  8 in total
  5 in total

1.  Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees.

Authors:  N Lepage; A Leroyer; N Cherot-Kornobis; I Lartigau; S Miczek; A Sobaszek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-15       Impact factor: 3.267

2.  Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy.

Authors:  B Pinto; B Castagna; R Mattei; R Bruzzi; L Chiumiento; R Cristofani; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

3.  Implementation of Screening for Toxoplasma gondii Infection in Pregnancy.

Authors:  Massimo De Paschale; Carlo Agrappi; Maria Teresa Manco; Teresa Cerulli; Pierangelo Clerici
Journal:  J Clin Med Res       Date:  2010-05-19

4.  Use of a microquantity enzyme immunoassay in a large-scale study of measles, mumps and rubella immunity in Italy.

Authors:  F Condorelli; A Stivala; R Gallo; A Marino; C M Battaglini; A Messina; G Russo; A Castro; G Scalia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 5.103

5.  Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017.

Authors:  Daniela Fanigliulo; Serena Marchi; Emanuele Montomoli; Claudia Maria Trombetta
Journal:  Parasite       Date:  2020-01-14       Impact factor: 3.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.